The Trump Administration disrupted the routine and predictable evaluation process followed by the US Centers for Disease Control and Prevention to develop recommendations for vaccine usage, which could delay access to two new products.
CDC Advisory Committee Postponement Upends Complex Regulatory Choreography
The February meeting of US CDC’s Advisory Committee on Immunization Practices was indefinitely delayed to accommodate public comment, which did not open as scheduled on 3 February.
